Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

BACKGROUND: We aimed to assess the effectiveness of two doses of mRNA COVID-19 vaccines against COVID-19 with the original virus and other lineages circulating in France. METHODS: In this nationwide case-control study, cases were SARS-CoV-2 infected adults with onset of symptoms between 14 February...

Descripción completa

Detalles Bibliográficos
Autores principales: Charmet, Tiffany, Schaeffer, Laura, Grant, Rebecca, Galmiche, Simon, Chény, Olivia, Von Platen, Cassandre, Maurizot, Alexandra, Rogoff, Alexandra, Omar, Faïza, David, Christophe, Septfons, Alexandra, Cauchemez, Simon, Gaymard, Alexandre, Lina, Bruno, Lefrancois, Louise H, Enouf, Vincent, van der Werf, Sylvie, Mailles, Alexandra, Levy-Bruhl, Daniel, Carrat, Fabrice, Fontanet, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277121/
https://www.ncbi.nlm.nih.gov/pubmed/34278372
http://dx.doi.org/10.1016/j.lanepe.2021.100171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277121/
https://www.ncbi.nlm.nih.gov/pubmed/34278372
http://dx.doi.org/10.1016/j.lanepe.2021.100171

Ejemplares similares